Last updated: August 13, 2023
Sponsor: Indiana University
Overall Status: Completed
Phase
N/A
Condition
Stress
Vascular Diseases
Liver Disorders
Treatment
Velacur
Clinical Study ID
NCT04576897
LI for Portal Hypertenstion
2009698702
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adults aged 18 years or older
- Ability to provide informed consent
- Planned standard of care upper endoscopy to screen for varices
- Planned standard of care transjugular liver biopsy with portal pressure measurement
Exclusion
Exclusion Criteria:
- Inability or refusal to provide informed consent
- Fasting for less than three hours prior to the scan
- Subject is a pregnant or lactating female
- Subject with current, significant alcohol consumption
- Patients with a pacemaker or defibrillator
- Acute hepatitis defined as AST/ALT > 500 U/L
- Ascites
- post liver transplantation
Study Design
Total Participants: 70
Treatment Group(s): 1
Primary Treatment: Velacur
Phase:
Study Start date:
February 01, 2021
Estimated Completion Date:
April 19, 2022
Study Description
Connect with a study center
Indiana University Division of Gastroenterolgy and Hepatology
Indianapolis, Indiana 46202
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.